Medpace Voice

In a process-oriented industry that breathes deeply from a standard set of regulations, it is easy to see the importance of each storage unit in…

As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory…

As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…

Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.

While the CRO industry has grown primarily through mergers and acquisitions, Medpace has expanded through disciplined organic growth – expanding globally to operations in 36…

Experts from Medpace’s central laboratory evaluated the effect of hemolysis, icterus and lipemia on chemistry assays and assessed the association between the amount of interfering…

As part of our mission to deliver superb customer service and site support, we have recently expanded our kit building capabilities in the US and…

In this post, we highlight some of the key investments we have made in each of our biorepositories around the world and what that means…

With the advancement of precision medicine, molecular and genetic testing is becoming a critical component for patient selection and individual assessment of the risks and…

Data from central laboratories have been key for assessing safety, tolerability, and efficacy of new drugs in clinical trials. With the increasing complexity and global…